More cards in this set

Card 6

Front

Benefits of disease modifying strategies in PD

Back

Preview of the front of card 6

Card 7

Front

Design reasons why clinical trials have failed

Back

Preview of the front of card 7

Card 8

Front

How can we monitor DMS in clinical trials?

Back

Preview of the front of card 8

Card 9

Front

Why should we look for preclinical markers?

Back

Preview of the front of card 9

Card 10

Front

One important preclinical symptom

Back

Preview of the front of card 10

Card 11

Front

Another way of preclinical diagnosis

Back

Preview of the front of card 11

Card 12

Front

Problems w animal models

Back

Preview of the front of card 12

Card 13

Front

How can we monitor motor behaviour and NS tract

Back

Preview of the front of card 13

Card 14

Front

Key details of the -0HDA

Back

Preview of the front of card 14

Card 15

Front

Measures to assess 6-OHDA lesioned rats?

Back

Preview of the front of card 15
View more cards